German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
- Next story France widens COVID vaccine drive to 12 to 18-year-olds
- Previous story Vaccine protection may diminish need for yearly boosters
Explore more
- Germany resists calls to waive patents on Covid-19 vaccines
Germany is resisting momentum to lift patent protection for Covid-19 vaccines, saying... - Caring at home for yourself and others suffering from COVID-19
If you have coronavirus (COVID-19) and you’re caring for yourself at home... - Is “Rain” the Perfect Beatles Song?: A New Video Explores the Radical Innovations of the 1966 B-Side
“That one was the gift of God… of Ja actually—the god of... - Joseph D. Mount Was Charged For Organizing a Hike of More Than 150 people to the Grand Canyon.
Prosecutors said at least 150 people showed up, astounding rangers and overwhelming... - ‘Back to life’ on cafe terraces still a tiny COVID risk: experts
A return to enjoying drinks with friends on a cafe terrace, so... - 11-month-old baby killed and two children hurt after shots fired into a car
An 11-month-old baby girl died and two other children were hospitalized after... - We can’t believe how cheap the Apple Watch 3 is for Amazon Prime Day
The Apple Watch Series 3 is discounted by $30 in this year’s... - For Atlético Madrid, La Liga Title Is a Rare Opportunity
Atlético Madrid is positioned to lift the trophy in La Liga this... - A Bright Future for New York City’s Summer
The city’s beach and outdoor pool season is starting on schedule after... - Computational model demonstrates similarity in how humans and insects learn about their surroundings
Even the humble fruit fly craves a dose of the happy hormone,...